AVP(4-8) Improves Cognitive Behaviors and Hippocampal Synaptic Plasticity in the APP/PS1 Mouse Model of Alzheimer’s Disease
Memory deficits with aging are related to the neurodegeneration in the brain, including a reduction in arginine vasopressin (AVP) in the brain of patients with Alzheimer’s disease (AD). AVP(4-8), different from its precursor AVP, plays memory enhancement roles in the CNS without peripheral side-effects. However, it is not clear whether AVP(4-8) can improve cognitive behaviors and synaptic plasticity in the APP/PS1 mouse model of AD. Here, we investigated for the first time the neuroprotective effects of AVP(4-8) on memory behaviors and in vivo long-term potentiation (LTP) in APP/PS1-AD mice. The results showed that: (1) APP/PS1-AD mice had lower spontaneous alternation in the Y-maze than wild-type (WT) mice, and this was significantly reversed by AVP(4-8); (2) the prolonged escape latency of APP/PS1-AD mice in the Morris water maze was significantly decreased by AVP(4-8), and the decreased swimming time in target quadrant recovered significantly after AVP(4-8) treatment; (3) in vivo hippocampal LTP induced by high-frequency stimulation had a significant deficit in the AD mice, and this was partly rescued by AVP(4-8); (4) AVP(4-8) significantly up-regulated the expression levels of postsynaptic density 95 (PSD95) and nerve growth factor (NGF) in the hippocampus of AD mice. These results reveal the beneficial effects of AVP(4-8) in APP/PS1-AD mice, showing that the intranasal administration of AVP(4-8) effectively improved the working memory and long-term spatial memory of APP/PS1-AD mice, which may be associated with the elevation of PSD95 and NGF levels in the brain and the maintenance of hippocampal synaptic plasticity.
KeywordsAVP(4-8) APP/PS1 transgenic mice Cognitive behavior Synaptic plasticity In vivo hippocampal LTP
This work was supported by the National Natural Science Foundation of China (31471080), the Scientific Program for “Sanjin Scholars” of Shanxi Province, Shanxi “1331 Project” Key Subjects Construction (1331KSC), and Science Foundation for Excellent Young Scholars of Shanxi Province, China (201801D211005).
Conflict of interest
The authors claim no conflict of interest.
- 19.Hicks C, Ramos L, Reekie T, Misagh GH, Narlawar R, Kassiou M, et al. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. Br J Pharmacol 2014, 171: 2868–2887.PubMedPubMedCentralCrossRefGoogle Scholar
- 22.Wu JH, Du YC. Binding sites of ZNC(C)PR, a pentapeptide fragment of argipressin, in rat brain. Acta Pharmacol Sin 1995, 16: 141–144.Google Scholar
- 33.Reddy PH, Yin X, Manczak M, Kumar S, Pradeepkiran JA, Vijayan M, et al. Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease. Hum Mol Genet 2018, 27: 2502–2516.PubMedPubMedCentralCrossRefGoogle Scholar
- 35.Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, et al. Progressive accumulation of amyloid-beta oligomers in Alzheimer’s disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J 2010, 277: 3051–3067.PubMedPubMedCentralCrossRefGoogle Scholar
- 38.Qiao LY, Du YC. Involvement of a putative G-protein-coupled receptor and a branching pathway in argipressin (4-8) signal transduction in rat hippocampus. Acta Pharmacol Sin 1998, 19: 15–20.Google Scholar
- 40.Qiao LY, Chen XF, Gu BX, Wang TX, Du YC. Effect of AVP(4-8) administration on Ca2+/CaM-dependent protein kinase II autophosphorylation in rat brain. Acta Physiol Sin 1998, 50: 132–138.Google Scholar
- 41.Zhen X, Dong M, Du YC. Effect of arginine-vasopressin(4-8) on PKC and PKA activities in rat brain. Chin J Biochem Mol Biol 2000, 16: 529–532.Google Scholar
- 43.Guo J, Zhou AW, Du YC, Chen XF. AVP(4-8) increases NGF mRNA and protein content in rat hippocampus. Chin J Neurosci 1996, 3: 23–27.Google Scholar
- 48.Tiernan CT, Ginsberg SD, He B, Ward SM, Guillozet-Bongaarts AL, Kanaan NM, et al. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer’s disease. Neurobiol Dis 2018, 117: 125–136.PubMedPubMedCentralCrossRefGoogle Scholar